The compound alone or in combination with rapamycin, an mTOR inhibitor, showed significant growth inhibition in murine xenograft models of human pancreatic cancer cells OCIP19, 21, and 23 mediated by cell cycle arrest predominantly in G1 phase [130]. The gene discussed is MTOR; the disease is pancreatic neoplasm.